Orion Biotech Opportunities (Orion Biotech Opportunities) Capital Expenditure : $0.00 Mil (TTM As of Dec. 2022)

View and export this data going back to 2021. Start your Free Trial

What is Orion Biotech Opportunities Capital Expenditure?

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Orion Biotech Opportunities's cash flow for capital expenditures for the three months ended in Dec. 2022 was $0.00 Mil. Its cash flow for capital expenditures for the trailing twelve months (TTM) ended in Dec. 2022 was $0.00 Mil.

Orion Biotech Opportunities Capital Expenditure Historical Data

The historical data trend for Orion Biotech Opportunities's Capital Expenditure can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Orion Biotech Opportunities Capital Expenditure Chart

Orion Biotech Opportunities Annual Data

Trend

Dec21

Dec22

Capital Expenditure

Orion Biotech Opportunities Quarterly Data
	Feb21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22
Capital Expenditure	Get a 7-Day Free Trial			-	-	-	-	-

Orion Biotech Opportunities Capital Expenditure Calculation

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Capital Expenditure for the trailing twelve months (TTM) ended in Dec. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.